Changes in Central Aortic Pressure, Endothelial Function and Biomarkers in Hypertensive African-Americans with the Cardiometabolic Syndrome: Comparison of Amlodipine/Olmesartan versus Hydrochlorothiazide/Losartan

Sixty-six self-identified African-American subjects with stage 1 and 2 hypertension and characteristics of the cardiometabolic syndrome were treated with amlodipine/olmesartan (A/O) versus losartan/hydrochlorothiazide (L/H) for 20 weeks in an open-label, active comparator fashion. Subjects not meeti...

Full description

Saved in:
Bibliographic Details
Published in:Cardiorenal medicine 2013-12, Vol.3 (4), p.221-231
Main Authors: Khan, Bobby V., Merchant, Nadya, Rahman, Syed T., Ahmad, Mushtaq, Parrott, Janice M., Umar, Kanwal, Johnson, Julie, Ferdinand, Keith C.
Format: Article
Language:English
Subjects:
Original Paper
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Sixty-six self-identified African-American subjects with stage 1 and 2 hypertension and characteristics of the cardiometabolic syndrome were treated with amlodipine/olmesartan (A/O) versus losartan/hydrochlorothiazide (L/H) for 20 weeks in an open-label, active comparator fashion. Subjects not meeting a blood pressure (BP) value of
ISSN:1664-3828
1664-5502
DOI:10.1159/000355136